A 28-year-old man with newly diagnosed HIV (CD4 count 45 cells/μL) presents with oral white plaques that do not scrape off easily and esophageal dysphagia. Oral candidiasis is suspected. Which investigation is most appropriate to confirm esophageal candidiasis and assess for other opportunistic infections?

## Investigation of Choice for Esophageal Candidiasis in Advanced HIV ### Clinical Context This patient has severe immunosuppression (CD4 <50 cells/μL) with clinical signs of esophageal candidiasis (dysphagia, oral plaques). Esophageal candidiasis is an AIDS-defining illness and requires definitive diagnosis because: - Dysphagia in advanced HIV may have multiple etiologies (HSV, CMV, aphthous ulcers) - Endoscopy allows direct visualization, biopsy, and exclusion of other serious pathogens - Fungal culture enables species identification and antifungal susceptibility testing ### Why Endoscopy with Biopsy is Optimal **Key Point:** Upper GI endoscopy with esophageal biopsy and fungal culture is the **gold standard** for confirming esophageal candidiasis because it: - Provides **direct visualization** of white plaques, erythema, or ulceration - Allows **tissue sampling** for histopathology (pseudohyphae, budding yeast in epithelium) - Enables **fungal culture** for species identification (*C. albicans* vs. non-*albicans* species) - Permits **antifungal susceptibility testing** in cases of treatment failure - Simultaneously excludes other serious pathogens: HSV esophagitis, CMV ulcers, lymphoma **High-Yield:** Endoscopy is indicated when: - Dysphagia persists despite empiric antifungal therapy (fluconazole) - CD4 count <50 cells/μL (high risk for non-*albicans* *Candida* and resistance) - Need to rule out alternative diagnoses (HSV, CMV, malignancy) ### Diagnostic Findings on Endoscopy | Finding | Candidiasis | HSV Esophagitis | CMV Esophagitis | |---------|-------------|-----------------|------------------| | Appearance | White plaques, erythema | Vesicles, shallow ulcers | Large, deep ulcers | | Location | Diffuse | Proximal/mid esophagus | Distal esophagus | | Biopsy | Pseudohyphae in epithelium | Ballooning, Cowdry A bodies | Intranuclear/cytoplasmic inclusions | | Culture | *Candida* growth | HSV PCR/culture | CMV culture/PCR | ### Histopathology of Candida Esophagitis **Clinical Pearl:** On esophageal biopsy: - **Pseudohyphae and budding yeast** invade the epithelium - Minimal inflammation (unlike HSV or CMV) - PAS stain highlights fungal elements - Confirms invasive candidiasis (not just colonization) ### Management After Diagnosis **Mnemonic: "FLUCON" for esophageal candidiasis in advanced HIV** - **F**luconazole 200–400 mg daily is first-line (oral or IV) - **L**ow CD4 (<50) → higher risk of resistance → monitor response - **U**nresponsive cases → switch to caspofungin or amphotericin B - **C**ulture guides susceptibility-directed therapy - **O**ral candidiasis often coexists; treat simultaneously - **N**eed CD4 recovery with ART (target >100 cells/μL)